Skip to main content

Table 1 Characteristics for the whole group, women with 12-month, past and no past depressive or anxiety disorder

From: Psychiatric disorders, psychotropic medication use and falls among women: an observational study

  Depressive disorders Anxiety disorders
  All 12 month depression Past depression Never p 12 month anxiety Past anxiety Never p
  n = 146 n = 148 n = 768   n = 99 n = 40 n = 923  
Age (yr) 50.0 (33.5-65.0) 47.0 (33.8-59.0)a 46.5 (29.0-59.8)a 52.0 (35.0-68.0) <0.001 44.0 (29.0-56.0)b 54.0 (32.8-64.8) 51.0 (34.0-67.0) 0.008
Weight (kg) 69.4 (61.4-80.8) 72.9 (63.4-82.5)a 71.7 (62.8-79.9) 68.3 (60.9-80.3) 0.03 72.0 (63.4-80.5) 68.7 (60.4-80.2) 69.0 (61.2-81.0) 0.40
Smoking (current) 149 (14.0%) 33 (22.6%)a 22 (14.9%) 94 (12.2%) 0.004 21 (21.2%) 6 (15.0%) 122 (13.2%) 0.09
Systolic BP (mmHg) 125.1 ± 17.5 124.2 ± 17.0 123.5 ± 14.7 125.5 ± 18.0 0.41 122.2 ± 17.8 126.7 ± 16.8 125.0 ± 17.4 0.25
Diastolic BP (mmHg) 75.7 ± 11.0 78.0 ± 10.9a 74.9 ± 9.9 75.4 ± 11.1 0.03 76.1 ± 11.5 76.8 ± 10.7 75.6 ± 10.9 0.75
Mobility (current)      0.10     0.36
 Active 831 (78.4%) 107 (73.3%) 123 (83.7%) 601 (78.4%)   74 (74.8%) 34 (85.0%) 723 (78.5%)  
 Sedentary 174 (16.4%) 32 (21.9%) 21 (14.3%) 121 (15.8%)   21 (21.2%) 3 (7.5%) 150 (16.3%)  
 Limited 55 (5.2%) 7 (5.3%) 3 (2.3%) 45 (5.9%)   4 (4.0%) 3 (7.5%) 48 (5.2%)  
Walking aid (current) 58 (5.5%) 5 (3.4%)a 3 (2.0%)a 50 (6.5%) 0.05 5 (5.1%) 1 (2.5%) 52 (5.7%) 0.68
Health status (current)      <0.001     0.04
 Excellent-Very good 621 (58.6%) 64 (43.8%)a 83 (56.9%) 474 (61.8%)   48 (48.5%) b 20 (50.0%) 553 (60.1%)  
 Good 322 (30.4%) 52 (35.6%) 50 (34.3%) 220 (28.7%)   36 (36.4%)b 18 (45.0%)b 268 (29.1%)  
 Fair-Poor 116 (11.0%) 30 (20.6%)a 13 (8.9%) 73 (9.5%)   15 (15.2%) 2 (5.0%)b 99 (10.8%)  
Alcohol intake (g/d) 2.9 (0.4-12.1) 3.1 (0.4-14.8) 3.9 (0.5-14.7) 2.6 (0.3-10.6) 0.06 2.5 (0.3-13.5) 4.7 (0.4-12.4) 2.8 (0.4-11.7) 0.99
Calcium intake (mg/d) 836.9(607.6-1070.2) 836.1(556.6-1098.5) 794.2(572.6-1045.3) 840.6(617.6-1072.0) 0.43 787.8(549.2-1099.4) 920.1(676.2-1208.9) 836.3(608.1-1065.2) 0.32
Falls (2 or more) 56 (5.3%) 14 (9.6%)a 9 (6.1%) 33 (4.3%) 0.03 9 (9.1%) 4 (10.0%) 43 (4.7%) 0.07
Socioeconomic status      0.70     0.89
 Quintile 1 (most disadvantaged) 165 (15.4%) 28 (19.2%) 22 (14.9%) 115 (15.0%)   17 (17.2%) 7 (17.5%) 141 (15.3%)  
 Quintile 2 229 (21.6%) 32 (21.9%) 30 (20.3%) 167 (21.7%)   23 (23.2%) 6 (15.0%) 200 (21.7%)  
 Quintile 3 242 (22.8%) 32 (21.9%) 34 (23.0%) 176 (22.9%)   19 (19.2%) 11 (27.5%) 212 (23.0%)  
 Quintile 4 210 (19.8%) 31 (21.2%) 25 (16.9%) 154 (20.1%)   22 (22.2%) 6 (15.0%) 182 (19.7%)  
 Quintile 5 216 (20.3%) 23 (15.8%) 37 (25.0%) 156 (20.3%)   18 (18.2%) 10 (25.0%) 188 (20.4%)  
Psychotropic use (current) 159 (15.0%) 59 (40.4%)a 33 (23.3%)a 67 (8.7%) <0.001 29 (29.3%)b 16 (40.0%)b 114 (12.4%) <0.001
 benzodiazepine use 64 (6.0%) 16 (11.0%)a 9 (6.1%) 39 (5.1%) 0.02 13 (13.1%)b 5 (12.5%)b 46 (5.0%) 0.001
 antidepressant use 120 (11.3%) 54 (37.0%)a 27 (18.2%)a 39 (5.1%) <0.001 23 (23.2%)b 15 (37.5%)b 82 (8.9%) <0.001
  1. asignificantly different from no lifetime history of depressive disorders (never).
  2. bsignificantly different from no lifetime history of anxiety disorders (never).
  3. Values are given as mean (± SD), median (IQR) or n (%).
\